United Kingdom
The UK Focal Point on Drugs (the national focal point) is based in Public Health England. It works closely with the Home Office, other government departments and the devolved administrations (Northern Ireland, Scotland and Wales) in providing information to the EMCDDA. From 1 January 2021, the UK ceases to be a member of the Reitox network of national focal points.
News
Events
Publications
Publications related to this partner
Over the past quarter of a century, the EMCDDA has expanded its monitoring capability to keep pace with revolutionary changes in the extent and nature of the drugs problem and in the world in which we live.
Follow the timeline and take a walk through some of the key moments in the EMCDDA's 25 years of international cooperation.
This report presents the top-level overview of the drug situation in the United Kingdom, covering drug supply, use and public health problems as well as drug policy and responses.
Country Drug Reports provide a top-level overview of the drug phenomenon in European countries, covering topics such as drug supply, drug use and public health problems as well as drug policy and responses.
This report presents the top-level overview of the drug situation in the United Kingdom, covering drug supply, use and public health problems as well as drug policy and responses.
This report presents the top-level overview of the drug situation in the United Kingdom, covering drug supply, use and public health problems as well as drug policy and responses.
Document library
Contact information
UK Focal Point on Drugs, Public Health England
Ms Catherine Crawford
London
United Kingdom